Zoledronic acid affects the cytotoxic effects of Chlamydia pneumoniae and the modulation of cytokine production in human osteosarcoma cells

International Immunopharmacology

Volumn 22, Issue 1, 2014, Pages 66-72

  Rizzo, Antonietta ^a   Misso, Gabriella ^a   Bevilacqua, Nazario ^b   Donnarumma, Giovanna ^a   Lombardi, Angela ^a   Galdiero, Massimiliano ^a   Caraglia, Michele ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b CARDARELLI HOSPITAL   (Italy)

Author keywords

Bisphosphonates; Chlamydia pneumoniae; Cytokines; Cytotoxicity; Human osteosarcoma cells; Zoledronic acid

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CYTOKINE; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; ZOLEDRONIC ACID; ANTINEOPLASTIC AGENT; AUTACOID; IMIDAZOLE DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DRUG POTENCY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; NONHUMAN; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; SAOS 2 CELL LINE; APOPTOSIS; CELL GROWTH; CHLAMYDOPHILA INFECTIONS; DOSE RESPONSE; DRUG EFFECTS; GENETICS; IMMUNOLOGY; IMMUNOMODULATION; INNATE IMMUNITY; METABOLISM; MICROBIOLOGY; OSTEOSARCOMA; TUMOR CELL LINE; UPREGULATION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CYTOKINES; DIPHOSPHONATES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMIDAZOLES; IMMUNITY, INNATE; IMMUNOMODULATION; INFLAMMATION MEDIATORS; OSTEOSARCOMA; UP-REGULATION;

EID: 84903768712     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2014.06.019     Document Type: Article

References (47)

1. H.A. Saka, and R.H. Valdivia Acquisition of nutrients by Chlamydiae: unique challenges of living in an intracellular compartment Curr Opin Microbiol 13 2012 4 10
2. G. Tipples, and G. McClarty The obligate intracellular bacterium Chlamydia trachomatis is auxotrophic for three of the four ribonucleoside triphosphates Mol Microbiol 8 1993 1105 1114 (Pubitemid 23187029)
3. C.R. Carratelli, A. Rizzo, M.R. Catania, F. Gallè, E. Losi, and D.L. Hasty et al. Chlamydia pneumoniae infections prevent the programmed cell death on THP-1 cell line FEMS Microbiol Lett 215 2002 69 74 (Pubitemid 35232585)
4. M.E. Rottenberg, A. Gigliotti-Rothfuchs, D. Gigliotti, M. Ceausu, C. Une, and V. Levitsky et al. Regulation and role of IFN-gamma in the innate resistance to infection with Chlamydia pneumoniae J Immunol 164 2000 4812 4818 (Pubitemid 30238084)
5. P.J. Cook Antimicrobial therapy for Chlamydia pneumoniae: its potential role in atherosclerosis and asthma J Antimicrob Chemother 44 1999 145 148 (Pubitemid 29389276)
6. D.L. Mager Bacteria and cancer: cause, coincidence or cure? A review J Transl Med 4 2006 14
7. W.L. Beatty, G.I. Byrne, and R.P. Morrison Morphologic and antigenic characterization of interferon gamma-mediated persistent Chlamydia trachomatis infection in vitro Proc Natl Acad Sci USA 90 1993 3998 4002 (Pubitemid 23134153)
8. E.Y. Bragina, M.A. Gomberg, and G.A. Dmitriev Electron microscopic evidence of persistent chlamydial infection following treatment J Eur Acad Dermatol Venereol 15 2001 405 409 (Pubitemid 33048754)
9. R.J. Belland, D.E. Nelson, D. Virok, D.D. Crane, D. Hogan, and D. Sturdevant et al. Transcriptome analysis of chlamydial growth during IFN-gamma-mediated persistence and reactivation Proc Natl Acad Sci USA 100 2003 15971 15976 (Pubitemid 38021099)
10. A.R. Bhengraj, H. Vardhan, P. Srivastava, S. Salhan, and A. Mittal Decreased susceptibility to azithromycin and doxycycline in clinical isolates of Chlamydia trachomatis obtained from recurrently infected female patients in India Chemotherapy 56 2010 371 377
11. H. Ikejima, H. Friedman, and Y. Yamamoto Chlamydia pneumoniae infection of microglial cells in vitro: a model of microbial infection for neurological disease J Med Microbiol 55 2006 947 952 (Pubitemid 43974703)
12. A. Rizzo, M. Di Domenico, C.R. Carratelli, N. Mazzola, and R. Paolillo Induction of proinflammatory cytokines in human osteoblastic cells by Chlamydia pneumoniae Cytokine 56 2011 450 457
13. I. Marriott Osteoblast responses to bacterial pathogens: a previously unappreciated role for bone-forming cells in host defense and disease progression Immunol Res 30 2004 291 308 (Pubitemid 39546231)
14. C. Contini, S. Seraceni, R. Cultrera, M. Castellazzi, E. Granieri, and E. Fainardi Chlamydophila pneumoniae infection and its role in neurological disorders Interdiscip Perspect Infect Dis 2010 273573
15. A. Rizzo, N. Bevilacqua, L. Guida, M. Annunziata, C. Romano Carratelli, and R. Paolillo Effect of resveratrol and modulation of cytokine production on human periodontal ligament cells Cytokine 60 2012 197 204
16. F.P. Koch, A. Wunsch, C. Merkel, T. Ziebart, A. Pabst, and S.S. Yekta et al. The influence of bisphosphonates on human osteoblast migration and integrin aVb3/tenascin C gene expression in vitro Head Face Med 7 2011 4
17. T.T. Hung, J. Chan, P.J. Russell, and C.A. Power Zoledronic acid preserves bone structure and increases survival but does not limit tumour incidence in a prostate cancer bone metastasis model PLoS ONE 6 2011 e19389
18. M. Caraglia, D. Santini, M. Marra, B. Vincenzi, G. Tonini, and A. Budillon Emerging anti-cancer molecular mechanisms of aminobisphosphonates Endocrinol Relat Cancer 13 2006 7 26
19. T. Yuasa, S. Kimura, E. Ashihara, T. Habuchi, and T. Maekawa Zoledronic acid - a multiplicity of anti-cancer action Curr Med Chem 14 2007 2126 2135 (Pubitemid 47578153)
20. M.C. Winter, I. Holen, and R.E. Coleman Exploring the anti-tumour activity of bisphosphonates in early breast cancer Cancer Treat Rev 34 2008 453 475
21. J.D. Bos, and M.L. Kapsenberg The skin immune system: progress in cutaneous biology Immunol Today 14 1993 75 78 (Pubitemid 23046167)
22. L.E. Cowen, and W.J. Steinbach Stress, drugs, and evolution: the role of cellular signalling in fungal drug resistance Eukaryot Cell 7 2008 747 764 (Pubitemid 351968819)
23. P.M. Roblin, W. Dumornay, and M.R. Hammerschlag Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae J Clin Microbiol 30 1992 1968 1971
24. B.K. Coombes, and J.B. Mahony Chlamydia pneumoniae infection of human endothelial cells induces proliferation of smooth muscle cells via an endothelial cell-derived soluble factor(s) Infect Immun 67 1999 2909 2915 (Pubitemid 29244707)
25. O. Salin, S. Alakurtti, L. Pohjala, A. Siiskonen, V. Maass, and M. Maass et al. Inhibitory effect of the natural product betulin and its derivatives against the intracellular bacterium Chlamydia pneumoniae Biochem Pharmacol 80 2010 1141 1151
26. S. Hirono, E. Dibrov, C. Hurtado, A. Kostenuk, R. Ducas, and G.N. Pierce Chlamydia pneumoniae stimulates proliferation of vascular smooth muscle cells through induction of endogenous Heat Shock Protein 60 Circ Res 93 2003 710 716 (Pubitemid 37288665)
27. E. Dolfini, L. Elli, L. Roncoroni, B. Costa, M.P. Colleoni, and V. Lorusso et al. Damaging effects of gliadin on three-dimensional cell culture model World J Gastroenterol 11 2005 5973 5977 (Pubitemid 41749210)
28. J. Alvesalo, H. Vuorela, P. Tammela, M. Leinonen, P. Saikku, and P. Vuorela Inhibitory effect of dietary phenolic compounds on Chlamydia pneumoniae in cell cultures Biochem Pharmacol 71 2006 735 741 (Pubitemid 43208829)
29. J. Cazalis, S. Tanabe, G. Gagnon, T. Sorsa, and D. Grenier Tetracyclines and chemically modified tetracycline-3 (CMT-3) modulate cytokine secretion by lipopolysaccharide-stimulated whole blood Inflammation 32 2009 130 137
30. D. Santini, G. Schiavon, S. Angeletti, B. Vincenzi, S. Gasparro, and C. Grilli et al. Last generation of amino-bisphosphonates (N-BPs) and cancer angio-genesis: a new role for these drugs? Recent Pat Anticancer Drug Discov 1 2006 383 396
31. G. Misso, M. Porru, A. Stoppacciaro, M. Castellano, F. De Cicco, and C. Leonetti et al. Evaluation of the in vitro and in vivo antiangiogenic effects of denosumab and zoledronic acid Cancer Biol Ther 13 2012 1491 1500
32. M.J. Simon, P. Niehoff, B. Kimmig, J. Wiltfang, and Y. Açil Expression profile and synthesis of different collagen types I, II, III, and V of human gingival fibroblasts, osteoblasts, and SaOS-2 cells after bisphosphonate treatment Clin Oral Investig 14 2010 51 58
33. C. Walter, M.O. Klein, A. Pabst, B. Al-Nawas, H. Duschner, and T. Ziebart Influence of bisphosphonates on endothelial cells, fibroblasts, and osteogenic cells Clin Oral Investig 14 2010 35 41
34. M. Caraglia, M. Marra, C. Leonetti, G. Meo, A.M. D'Alessandro, and A. Baldi et al. R115777 (Zarnestra)/Zoledronic acid (Zometa) cooperation on inhibition of prostate cancer proliferation is paralleled by Erk/Akt inactivation and reduced Bcl-2 and bad phosphorylation J Cell Physiol 211 2007 533 543 (Pubitemid 46580107)
35. Y. Açil, B. Möller, P. Niehoff, K. Rachko, V. Gassling, and J. Wiltfang et al. The cytotoxic effects of three different bisphosphonates in-vitro on human gingival fibroblasts, osteoblasts and osteogenic sarcoma cells J Craniomaxillofac Surg 40 2012 e229 e235
36. G. De Rosa, G. Misso, G. Salzano, and M. Caraglia Bisphosphonates and cancer: what opportunities from nanotechnology? J Drug Deliv 2013 637976
37. K.J. August, A. Dalton, H.M. Katzenstein, B. George, T.A. Olson, and K. Wasilewski-Masker et al. The use of zoledronic acid in pediatric cancer patients Pediatr Blood Cancer 56 2011 610 614
38. A. Rizzo, M.D. Domenico, C.R. Carratelli, and R. Paolillo The role of Chlamydia and Chlamydophila infections in reactive arthritis Intern Med 51 2012 113 117
39. N. Olmez, G.F. Wang, Y. Li, H. Zhang, and H.R. Schumacher Chlamydial nucleic acids in synovium in osteoarthritis: what are the implications? J Rheumatol 28 2011 1874 1880
40. M.V. Delpino, C.A. Fossati, and P.C. Baldi Proinflammatory response of human osteoblastic cell lines and osteoblast-monocyte interaction upon infection with Brucella spp Infect Immun 77 2009 984 995
41. K.E. de Visser, A. Eichten, and L.M. Coussens Paradoxical roles of the immune system during cancer development Nat Rev Cancer 6 2006 24 37 (Pubitemid 43053650)
42. M.A. Scidmore Recent advances in Chlamydia subversion of host cytoskeletal and membrane trafficking pathways Microbes Infect 13 2011 527 535
43. D. Thiébaud, A. Sauty, P. Burckhardt, P. Leuenberger, L. Sitzler, and J.R. Green et al. An in vitro and in vivo study of cytokines in the acute-phase response associated with bisphosphonates Calcif Tissue Int 61 1997 386 392 (Pubitemid 27507904)
44. C.Y. Chiang, G. Kyritsis, D.T. Graves, and S. Amar Interleukin-1 and tumor necrosis factor activities partially account for calvarial bone resorption induced by local injection of lipopolysaccharide Infect Immun 67 1999 4231 4236 (Pubitemid 29357050)
45. J.H. Meurman, M. Sanz, and S.J. Janket Oral health, atherosclerosis, and cardiovascular disease Crit Rev Oral Biol Med 15 2004 403 413 (Pubitemid 44567524)
46. D. Muratsu, D. Yoshiga, T. Taketomi, T. Onimura, Y. Seki, and A. Matsumoto et al. Zoledronic acid enhances lipopolysaccharide-stimulated proinflammatory reactions through controlled expression of SOCS1 in macrophages PLoS ONE 8 2013 e67906
47. J. Thalmann, K. Janik, M. May, K. Sommer, J. Ebeling, and F. Hofmann et al. Actin re-organization induced by Chlamydia trachomatis serovar D-evidence for a critical role of the effector protein CT166 targeting Rac PLoS ONE 5 2010 e9887